4.8 Article

Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes

Journal

BIOMATERIALS
Volume 33, Issue 11, Pages 3334-3343

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2012.01.024

Keywords

Nanomaterials; Carbon nanotubes; Cell uptake; Inhibitors; Phagocytosis; Endocytosis

Funding

  1. School of Pharmacy, University of London
  2. CNRS
  3. Agence Nationale de la Recherche [ANR-05-JCJC-0031-01]
  4. Italian Ministry of Education MIUR [cofin Prot. 20085M27SS, FIRB prot. RBAP11ETKA]
  5. European Union through the ERC Advanced Grant Carbonanobridge [227135]
  6. Regione Friuli-Venezia Giulia
  7. Portuguese Foundation for Science and Technology (FCT/MCTES) [SFRH/BD/21845/2005]
  8. European Union [HEALTH-2007-201587]
  9. PICS (Project for International Scientific Cooperation)
  10. European Research Council (ERC) [227135] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Understanding the mechanisms responsible for carbon nanotube (CNT) internalisation into live cells is considered critical both from a fundamental point of view and for further engineering of CNT-based delivery systems to intracellular targets. While several studies are focused on the development of such CNT-based delivery systems, attempts to systematically elucidate the cellular uptake mechanisms of CNTs are still rather limited. The aim of the present study is to evaluate the cellular internalisation of chemically functionalised multi-walled carbon nanotubes (f-MWCNTs) in the presence of different well-known cellular uptake inhibitors. Our data reveal how f-MWCNTs are able to translocate across cell membranes of both phagocytic and non-phagocytic cell lines. We have evidenced that at least 30-50% of f-MWCNTs are taken up by cells through an energy-independent mechanism. This characteristic makes nanotubes loaded with therapeutic or diagnostic cargos extremely interesting as the release of active molecules directly into the cytoplasm increase their biological activity and therapeutic efficacy. (c) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available